The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Stevie K and Charles + Lee Brands

27 Feb 2017 07:00

RNS Number : 8265X
InnovaDerma PLC
27 February 2017
 

InnovaDerma PLC

("InnovaDerma", the "Company" or the "Group")

Acquisition of Stevie K and Charles + Lee brands

InnovaDerma (LSE: IDP), a UK developer of 'at-home' and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation, is pleased to announce it has acquired the Intellectual Property and Assets of the 'Stevie K' and 'Charles + Lee' brands from Stevie K Cosmetics Pty Ltd and Charles + Lee Pty Ltd (the "Vendors"). Stevie K is an Australian made line of cosmetics and Charles + Lee is a range of men's skincare (the "Acquisitions").

 

In line with InnovaDerma's acquisition model, Kate Fissenden, the founder of Stevie K and Charles + Lee brands, will be incentivised as a General Manager in the Group, responsible for the growth and development of both brands. Kate has more than 10 years' experience with some of Australia's leading beauty brands and has expertise in product development and brand management. To support the success of the brands, the minimum term of Kate's employment contract with the Group is three years.

 

The purchase price for the Acquisitions is AUS$50,000 (the "Purchase Price"). The Vendors have the option to convert the Purchase Price into ordinary shares of InnovaDerma within 14 days of completion. If the Vendors exercise the Option, it will be satisfied by the issuance of approximately 39,700 ordinary shares in InnovaDerma (the exact number of shares will be calculated based on the average market price of the shares).

 

About Stevie K and Charles + Lee

 

· Stevie K is an award winning, mid-premium priced, bold range of cosmetics with strong branding and eye-catching packaging targeted at the irreverent individual in the Millennial and Generation Zero market. Founded in 2016, the brand is positioned as Australian made, cruelty free, high quality and edgy. Stevie K deliberately avoids conventional marketing channels and has strong association within the beauty and lifestyle digital platforms. It is well-suited for social media with its extensive range of striking colours and unconventional style. Announced twice as the "Best New Aussie Beauty Brand" by national print and digital media, Stevie K is currently sold online in Australia, the UK, and New Zealand. http://www.steviekcosmetics.com/

 

· Charles + Lee is an affordable alternative premium range of men's skincare, marketed as an effective and understated brand, containing natural and organic ingredients. It is cruelty free and has been certified by the Roundtable on Sustainable Palm Oil Association. The products are Australian made, currently sold online at the brand's own website and online at Urban Outfitters in Australia, New Zealand, the US, and Canada. http://charlesandlee.com

Benefits of the Acquisitions

The Company has previously stated its intention to acquire brands which are ready to market and complementary to its existing portfolio. There are significant opportunities for a number of commercial, operational and financial synergies, which are expected to create value for InnovaDerma's shareholders:

· Stevie K and Charles + Lee are highly differentiated, innovative brands and provide the Company with entry into the alternative premium end of the make-up and men's skincare market;

· There is existing and growing demand for high quality make-up and men's skincare which is ethical, natural and alternative. These concepts fit with the international perception of Australian lifestyle, and therefore the Company will seek to harness these as part of its marketing strategy;

· Both brands are well-suited for social media and have already developed a strong following which is key to driving brand loyalty and revenue;

· The current geographic footprint of the Acquisitions fits well with the Company's established presence in Australia, UK and the US;

· With InnovaDerma's strong distribution network in nine countries and a growing Direct-to-Consumer ("DTC") Platform with proven social media campaigns, the Board believes there is an opportunity to grow revenues of the Acquisitions by accessing these home-grown channels;

· The Board does not envisage significant integration costs arising from the Acquisitions;

· The Company expects the Acquisitions to be revenue and earnings enhancing from the last quarter of the financial year.

Haris Chaudhry, Executive Chairman of InnovaDerma said:

"Stevie K and Charles + Lee are an excellent strategic fit for InnovaDerma and we are pleased to have acquired such highly differentiated brands which the Board believes will bring considerable international growth opportunities. We welcome Kate Fissenden to the Company and look forward to working with her to drive profitable growth in the future."

Further enquiries:

InnovaDerma

Haris Chaudhry/Joe Bayer

 

+61 (0)3 9111 0071

Sole broker

Hybridan LLP

Claire Noyce

 

+44 (0)203 764 2341

Cardew Group

Shan Shan Willenbrock

David Roach

Emma Ruttle

 

+ 44 (0)20 7930 0777

 

About InnovaDerma:

InnovaDerma PLC (LSE: IDP) specializes in the research, manufacture and marketing of clinically proven products in life sciences, beauty and personal care products. InnovaDerma has presence in the UK, US, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.

 

www.innovaderma.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQSEUFDLFWSEDE
Date   Source Headline
15th Feb 202112:22 pmBUSForm 8.3 - INNOVADERMA PLC
12th Feb 20216:25 pmRNSForm 8.3 - Innovaderma PLC
12th Feb 20214:43 pmRNSForm 8.3 - [InnovaDerma plc]
12th Feb 20214:40 pmRNSForm 8.3 - [InnovaDerma plc]
12th Feb 20212:35 pmRNSForm 8.3 - Creightons
11th Feb 202111:50 amRNSForm 8.3 - Innovaderma plc
10th Feb 202111:25 amRNSForm 8.3 - Innovaderma plc
10th Feb 202111:03 amRNSForm 8.3 - Innovaderma PLC
9th Feb 20211:18 pmBUSForm 8.3 - INNOVADERMA PLC
5th Feb 20215:14 pmRNSForm 8.3 - Innovaderma Plc
4th Feb 20215:37 pmRNSForm 8 (OPD) CREIGHTONS
4th Feb 20213:31 pmRNSForm 8 (OPD) InnovaDerma PLC
3rd Feb 202112:27 pmBUSForm 8.3 - Innovaderma Plc
2nd Feb 20214:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20214:35 pmRNSPrice Monitoring Extension
2nd Feb 20214:12 pmGNWForm 8.3 - [InnovaDerma plc]
2nd Feb 20212:05 pmRNSSecond Price Monitoring Extn
2nd Feb 20212:00 pmRNSPrice Monitoring Extension
2nd Feb 202111:41 amRNSStatement re Possible Offer
2nd Feb 202111:05 amRNSSecond Price Monitoring Extn
2nd Feb 202111:00 amRNSPrice Monitoring Extension
2nd Feb 20219:05 amRNSSecond Price Monitoring Extn
2nd Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 202111:22 amRNSHolding(s) in Company
22nd Jan 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
20th Jan 20219:19 amRNSProposed Placing and Proposed Open Offer
18th Jan 202111:59 amRNSHolding(s) in Company
15th Jan 20214:41 pmRNSSecond Price Monitoring Extn
15th Jan 20214:35 pmRNSPrice Monitoring Extension
15th Jan 20217:00 amRNSLoan Agreement
11th Jan 20217:08 amRNSTrading Statement
16th Dec 202012:18 pmRNSResults of the AGM and GM and Directorate Change
2nd Dec 20207:00 amRNSDirectorate Change
24th Nov 20207:02 amRNSDirectorate Change
24th Nov 20207:00 amRNSNotice of General Meeting and adjournment of AGM
18th Nov 20207:00 amRNSDirectorate Change
11th Nov 202012:07 pmRNSAdjournment of AGM
29th Oct 20208:45 amRNSHolding(s) in Company
29th Oct 20208:28 amRNSDirector/PDMR Shareholding
27th Oct 20204:41 pmRNSSecond Price Monitoring Extn
27th Oct 20204:36 pmRNSPrice Monitoring Extension
27th Oct 20202:05 pmRNSSecond Price Monitoring Extn
27th Oct 20202:01 pmRNSPrice Monitoring Extension
23rd Oct 20202:05 pmRNSRequisition notice and Progress of CEO appointment
16th Oct 20204:32 pmRNSNotice of AGM
16th Oct 20209:21 amRNSAppointment of Non-executive Director
15th Oct 20204:40 pmRNSSecond Price Monitoring Extn
15th Oct 20204:35 pmRNSPrice Monitoring Extension
15th Oct 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.